Plunkett Research Online: Yuhan Corporation

YUHAN CORPORATION (000100) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Yuhan Corporation is a pharmaceuticals company that develops drugs for diabetes, viral and fungus infection, osteoporosis, arthritis, cancer and hepatitis C. Yuhan’s first fully developed drug was Revanex, an anti-ulcer agent for gastrointestinal diseases. The firm conducts its research through th.....


YUHAN CORPORATION

Ticker: 000100
Exchange: Seoul
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 82-2-828-0181
Fax: 82-2-828-0050
Address: 74, Noryangjin-ro, dongjak-gu
Seoul, 06927 South Korea

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

Wook Je ChoCEO/Pres.
Chris C.K. SaDir.-New Prod. Dev.
See More
Yuhan Corporation is a pharmaceuticals company that develops drugs for diabetes, viral and fungus infection, osteoporosis, arthritis, cancer and hepatitis C. Yuhan’s first fully developed drug was Revanex, an anti-ulcer agent for gastrointestinal diseases. The firm conducts its research through th.....See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture